Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.

A mass spectrometric method was developed to elucidate the N-glycan structures of serum glycoproteins and utilize fucosylated glycans as potential markers for pancreatic cancer. This assay was applied to haptoglobin in human serum where N-glycans derived from the serum of 16 pancreatic cancer patients were compared with those from 15 individuals with benign conditions (5 normals, 5 chronic pancreatitis, and 5 type II diabetes). This assay used only 10 μL of serum where haptoglobin was extracted using a monoclonal antibody and quantitative permethylation was performed on desialylated N-glycans followed by MALDI-QIT-TOF MS analysis. Eight desialylated N-glycan structures of haptoglobin were identified where a bifucosylated triantennary structure was reported for the first time in pancreatic cancer samples. Both core and antennary fucosylation were elevated in pancreatic cancer samples compared to samples from benign conditions. Fucosylation degree indices were calculated and show a significant difference between pancreatic cancer patients of all stages and the benign conditions analyzed. This study demonstrates that a serum assay based on haptoglobin fucosylation patterns using mass spectrometric analysis may serve as a novel method for the diagnosis of pancreatic cancer.

[1]  Karen Willcox,et al.  Kinetics and kinematics for translational motions in microgravity during parabolic flight. , 2009, Aviation, space, and environmental medicine.

[2]  S. Thompson,et al.  Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. , 1992, Cancer letters.

[3]  S. Hakomori,et al.  N‐glycosylation status of β‐haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects , 2009, International journal of cancer.

[4]  W. Dobryszycka,et al.  Biological functions of haptoglobin--new pieces to an old puzzle. , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[5]  Kerby Shedden,et al.  Glycoprotein microarrays with multi-lectin detection: unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. , 2007, Journal of proteome research.

[6]  S. Koide,et al.  Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. , 1996, Cancer research.

[7]  M. Tajiri,et al.  Site‐specific analysis of N‐glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers , 2008, International journal of cancer.

[8]  Osamu Ishikawa,et al.  Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation , 2006, International journal of cancer.

[9]  C. Rosty,et al.  Early detection of pancreatic carcinoma. , 2002, Hematology/oncology clinics of North America.

[10]  Lori J Sokoll,et al.  Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. , 2009, Journal of proteome research.

[11]  K. Khoo,et al.  Distinctive characteristics of MALDI-Q/TOF and TOF/TOF tandem mass spectrometry for sequencing of permethylated complex type N-glycans , 2006, Glycoconjugate Journal.

[12]  Yehia Mechref,et al.  Solid-phase permethylation of glycans for mass spectrometric analysis. , 2005, Rapid communications in mass spectrometry : RCM.

[13]  Scott R. Kronewitter,et al.  Glycomics and disease markers. , 2009, Current opinion in chemical biology.

[14]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[15]  F. Regnier,et al.  Use of a lectin affinity selector in the search for unusual glycosylation in proteomics. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  M. Sherman,et al.  Clinical Utility of AFP-L3% Measurement in North American Patients with HCV-Related Cirrhosis , 2007, The American Journal of Gastroenterology.

[17]  Károly Héberger,et al.  Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals. , 2008, Journal of proteomics.

[18]  H. Inoue,et al.  Expression of α-1,3-Fucosyltransferase Type IV and VII Genes Is Related to Poor Prognosis in Lung Cancer , 1996 .

[19]  I. Wilson,et al.  Fucose in N-glycans: from plant to man. , 1999, Biochimica et biophysica acta.

[20]  H. Matsumoto,et al.  Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer , 2010, Clinical chemistry and laboratory medicine.

[21]  D. Simeone,et al.  N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. , 2007, Journal of proteome research.

[22]  D. Harvey,et al.  Fragmentation of N-linked glycans with a matrix-assisted laser desorption/ionization ion trap time-of-flight mass spectrometer. , 2004, Rapid communications in mass spectrometry : RCM.

[23]  Y. Mechref,et al.  Comparative glycomic profiling in esophageal adenocarcinoma. , 2010, The Journal of thoracic and cardiovascular surgery.

[24]  W. Hancock,et al.  Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. , 2006, Clinical chemistry.

[25]  Kit S. Lam,et al.  A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.

[26]  Naoyuki Taniguchi,et al.  Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. , 2007, Glycobiology.

[27]  Terence C W Poon,et al.  Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. , 2006, Journal of proteome research.

[28]  D. Lombardo,et al.  Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. , 1998, Glycobiology.

[29]  Yung-Hun Yang,et al.  Rapid and high-throughput analysis of N-glycans from ovarian cancer serum using a 96-well plate platform. , 2009, Analytical biochemistry.

[30]  I. Rudan,et al.  Common aberrations from the normal human plasma N-glycan profile. , 2010, Glycobiology.

[31]  P. Rudd,et al.  Glycosylation of liver acute‐phase proteins in pancreatic cancer and chronic pancreatitis , 2010, Proteomics. Clinical applications.

[32]  D. Harvey,et al.  Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. , 1999, Mass spectrometry reviews.

[33]  J. Gottesman,et al.  N-glycosylation status of beta-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases. , 2009, International journal of oncology.

[34]  K. Murayama,et al.  Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects , 2008, International journal of cancer.